Induction of drug-metabolizing enzymes
5a), a pro-drug that combines sulphapyridine (an antibiotic) and 5-aminosalicylic (an anti-inflammatory agent) linked by an azo bridge, has huge therapeutic potential, but is, unfortunately, labile under physiological conditions (70% degradation by colonic bacteria via azo cleavage
Geralmente, seu uso feito com 2 cpsulas, ou 1 ampola, ou 1 colher de sopa de L-Carnitina, 1 hora antes de realizar atividade fsica, sempre com orientao do nutricionista
PeptideDeck will revise this article when a controlling agency action appears
FUS mutations in amyotrophic lateral sclerosis: clinical, pathological, neurophysiological and genetic analysis
"Nasal drug delivery: Pharmacokinetic and pharmacodynamic considerations." Advanced Drug Delivery Reviews